373 related articles for article (PubMed ID: 38203817)
1. Cytoskeleton Rearrangement in Podocytopathies: An Update.
Ma S; Qiu Y; Zhang C
Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203817
[TBL] [Abstract][Full Text] [Related]
2. A critical role of the podocyte cytoskeleton in the pathogenesis of glomerular proteinuria and autoimmune podocytopathies.
Ye Q; Lan B; Liu H; Persson PB; Lai EY; Mao J
Acta Physiol (Oxf); 2022 Aug; 235(4):e13850. PubMed ID: 35716094
[TBL] [Abstract][Full Text] [Related]
3. The Calcium-Dependent Protease Calpain-1 Links TRPC6 Activity to Podocyte Injury.
Verheijden KAT; Sonneveld R; Bakker-van Bebber M; Wetzels JFM; van der Vlag J; Nijenhuis T
J Am Soc Nephrol; 2018 Aug; 29(8):2099-2109. PubMed ID: 29954830
[TBL] [Abstract][Full Text] [Related]
4. Actin-associated Proteins in the Pathogenesis of Podocyte Injury.
He FF; Chen S; Su H; Meng XF; Zhang C
Curr Genomics; 2013 Nov; 14(7):477-84. PubMed ID: 24396279
[TBL] [Abstract][Full Text] [Related]
5. Nephrinuria and podocytopathies.
Kostovska I; Trajkovska KT; Topuzovska S; Cekovska S; Labudovic D; Kostovski O; Spasovski G
Adv Clin Chem; 2022; 108():1-36. PubMed ID: 35659057
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the Actin Cytoskeleton in Podocytes.
Blaine J; Dylewski J
Cells; 2020 Jul; 9(7):. PubMed ID: 32708597
[TBL] [Abstract][Full Text] [Related]
7. Actin dynamics at focal adhesions: a common endpoint and putative therapeutic target for proteinuric kidney diseases.
Sever S; Schiffer M
Kidney Int; 2018 Jun; 93(6):1298-1307. PubMed ID: 29678354
[TBL] [Abstract][Full Text] [Related]
8. Proteinuric Kidney Diseases: A Podocyte's Slit Diaphragm and Cytoskeleton Approach.
Yu SM; Nissaisorakarn P; Husain I; Jim B
Front Med (Lausanne); 2018; 5():221. PubMed ID: 30255020
[TBL] [Abstract][Full Text] [Related]
9. Current concepts of the podocyte in nephrotic syndrome.
Ding WY; Saleem MA
Kidney Res Clin Pract; 2012 Jun; 31(2):87-93. PubMed ID: 26889414
[TBL] [Abstract][Full Text] [Related]
10. Over-expressing transient receptor potential cation channel 6 in podocytes induces cytoskeleton rearrangement through increases of intracellular Ca2+ and RhoA activation.
Jiang L; Ding J; Tsai H; Li L; Feng Q; Miao J; Fan Q
Exp Biol Med (Maywood); 2011 Feb; 236(2):184-93. PubMed ID: 21321315
[TBL] [Abstract][Full Text] [Related]
11. Role of Transient Receptor Potential Canonical Channel 6 (TRPC6) in Diabetic Kidney Disease by Regulating Podocyte Actin Cytoskeleton Rearrangement.
Wang Q; Tian X; Wang Y; Wang Y; Li J; Zhao T; Li P
J Diabetes Res; 2020; 2020():6897390. PubMed ID: 31998809
[TBL] [Abstract][Full Text] [Related]
12. Insulin increases filtration barrier permeability via TRPC6-dependent activation of PKGIα signaling pathways.
Rogacka D; Audzeyenka I; Rachubik P; Rychłowski M; Kasztan M; Jankowski M; Angielski S; Piwkowska A
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1312-1325. PubMed ID: 28263796
[TBL] [Abstract][Full Text] [Related]
13. Calcium, TRPC channels, and regulation of the actin cytoskeleton in podocytes: towards a future of targeted therapies.
Wieder N; Greka A
Pediatr Nephrol; 2016 Jul; 31(7):1047-54. PubMed ID: 26490951
[TBL] [Abstract][Full Text] [Related]
14. Podocyte-actin dynamics in health and disease.
Perico L; Conti S; Benigni A; Remuzzi G
Nat Rev Nephrol; 2016 Nov; 12(11):692-710. PubMed ID: 27573725
[TBL] [Abstract][Full Text] [Related]
15. Calcium regulates podocyte actin dynamics.
Greka A; Mundel P
Semin Nephrol; 2012 Jul; 32(4):319-26. PubMed ID: 22958486
[TBL] [Abstract][Full Text] [Related]
16. Podocyte injury and targeting therapy: an update.
Durvasula RV; Shankland SJ
Curr Opin Nephrol Hypertens; 2006 Jan; 15(1):1-7. PubMed ID: 16340659
[TBL] [Abstract][Full Text] [Related]
17. Cytoskeleton Rearrangements Modulate TRPC6 Channel Activity in Podocytes.
Shalygin A; Shuyskiy LS; Bohovyk R; Palygin O; Staruschenko A; Kaznacheyeva E
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922367
[TBL] [Abstract][Full Text] [Related]
18. Podocytopathy: The role of actin cytoskeleton.
Ahmadian E; Eftekhari A; Atakishizada S; Valiyeva M; Ardalan M; Khalilov R; Kavetskyy T
Biomed Pharmacother; 2022 Dec; 156():113920. PubMed ID: 36411613
[TBL] [Abstract][Full Text] [Related]
19. Nephrin Tyrosine Phosphorylation Is Required to Stabilize and Restore Podocyte Foot Process Architecture.
New LA; Martin CE; Scott RP; Platt MJ; Keyvani Chahi A; Stringer CD; Lu P; Samborska B; Eremina V; Takano T; Simpson JA; Quaggin SE; Jones N
J Am Soc Nephrol; 2016 Aug; 27(8):2422-35. PubMed ID: 26802179
[TBL] [Abstract][Full Text] [Related]
20. Targeting podocyte-associated diseases.
Leeuwis JW; Nguyen TQ; Dendooven A; Kok RJ; Goldschmeding R
Adv Drug Deliv Rev; 2010 Nov; 62(14):1325-36. PubMed ID: 20828590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
